Keywords: endo, sales, reach, 440m, fiscal, usa-based, pain
Endo sales to reach $440M in fiscal 2003
Article | 06 January 2003
USA-based pain management firm Endo Pharmaceuticals has issuedfinancial guidance for fiscal 2003 which forecasts net sales to reach around $440 million and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
